CIMPLRX
LIVE

Serial Number

97077402

Owner

Cimplrx Co., Ltd.

Attorney

Boris Umansky

Filing Date

Oct 15, 2021

Add to watchlist:

No watchlists yet
View on USPTO

CIMPLRX Trademark

Serial Number: 97077402 • Registration: 7602990

CIMPLRX is a trademark filed by Cimplrx Co., Ltd. on October 15, 2021. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Cimplrx Co., Ltd. (3 trademarks)

5F, 114, Taebong-ro, Seocho-gu

Entity Type: 03

Trademark Details

Filing Date

October 15, 2021

Registration Date

December 17, 2024

Published for Opposition

October 15, 2024

Goods & Services

Downloadable computer software for drug discovery; downloadable computer programs for drug discovery; downloadable computer software for diagnosing diseases for medical purposes; recorded computer software for drug discovery; recorded computer programs for drug discovery; recorded computer software for diagnosing diseases for medical purposes; downloadable data processing software; recorded data processing software; downloadable computer software to enable searching of data; recorded computer software to enable searching of data; downloadable database management software applications; downloadable computer software for creating searchable databases; recorded computer software for creating searchable databases; downloadable computer software for accessing information directories that may be downloaded from the global computer network; recorded computer software for accessing information directories that may be downloaded from the global computer network; downloadable computer software for use in providing multiple user access to a global computer information network; recorded computer software for use in providing multiple user access to a global computer information network; downloadable computer operating system software; recorded computer operating system software

New pharmaceutical research and development; drug discovery services; conducting early evaluations in the field of new pharmaceuticals; research relating to pharmaceuticals; pharmaceutical drug development services; pharmaceutical research and development; laboratory research in the field of pharmaceuticals; research and development of vaccines and medicines; medicine research; providing information on research and development of new products, namely, information on the testing, inspection, and research of medical products; scientific research in the field of pharmaceuticals; scientific research in the fields of biomedicine; development of computer software for drug discovery; development and creation of computer programmes for data processing; providing online non downloadable software for drug discovery; providing online non downloadable software for diagnosing diseases for medical purposes; providing online non downloadable software for processing, searching, and creating data; providing online non downloadable software for accessing information directories that may be downloaded from the global computer network; providing online non downloadable software for use in providing multiple user access to a global computer information network; rental of software for drug discovery; updating and adapting of computer programs according to user requirements; software as a service (SaaS) featuring software for drug discovery; software as a service (SaaS) featuring software for diagnosing diseases for medical purposes; software as a service (SaaS) featuring software for processing, searching, and creating data; software as a service (SaaS) featuring software for accessing information directories that may be downloaded from the global computer network; software as a service (SaaS) featuring software for use in providing multiple user access to a global computer information network; providing PaaS (platform as a service) featuring software for drug discovery; providing PaaS (platform as a service) featuring software for diagnosing diseases for medical purposes; providing PaaS (platform as a service) featuring software for processing, searching, and creating data; providing PaaS (platform as a service) featuring software for accessing information directories that may be downloaded from the global computer network; providing PaaS (platform as a service) featuring software for use in providing multiple user access to a global computer information network

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Dec 17, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Dec 17, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 15, 2024 NPUB
PUBLISHED FOR OPPOSITION
Oct 15, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 25, 2024 NONP
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Feb 16, 2024 ERRR
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 13, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 26, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 26, 2024 CRFA
ASSIGNED TO LIE
Jan 26, 2024 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Sep 7, 2023 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Sep 7, 2023 GNS2
INQUIRY TO SUSPENSION E-MAILED
Sep 7, 2023 GNSI
SUSPENSION INQUIRY WRITTEN
Sep 7, 2023 CNSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Feb 21, 2023 GNS3
LETTER OF SUSPENSION E-MAILED
Feb 21, 2023 GNSL
SUSPENSION LETTER WRITTEN
Feb 21, 2023 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 26, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 25, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 25, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 26, 2022 GNRN
NON-FINAL ACTION E-MAILED
Jul 26, 2022 GNRT
NON-FINAL ACTION WRITTEN
Jul 26, 2022 CNRT
ASSIGNED TO EXAMINER
Jul 21, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 4, 2021 NWOS
NEW APPLICATION ENTERED
Oct 19, 2021 NWAP